Literature DB >> 31281062

Blood eosinophils as a continuous variable in the treatment of COPD: impact on the guidelines.

Maarten van den Berge1, Huib Am Kerstjens2.   

Abstract

Mesh：

Year:  2019        PMID： 31281062     DOI： 10.1016/S2213-2600(19)30195-X

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  5 in total

1.  Journal Club-COPD2020 Update. Global Initiative for Chronic Obstructive Lung Disease 2020 Report and the Journal of the COPD Foundation Special Edition, Moving to a New Definition for COPD: "COPDGene® 2019".

Authors:  Ron Balkissoon
Journal:  Chronic Obstr Pulm Dis       Date:  2019-10-23

Review 2.  Airway pharmacology: treatment options and algorithms to treat patients with chronic obstructive pulmonary disease.

Authors:  Huib A M Kerstjens; John W Upham; Ian A Yang
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 3.  Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine.

Authors:  Corry-Anke Brandsma; Maarten Van den Berge; Tillie-Louise Hackett; Guy Brusselle; Wim Timens
Journal:  J Pathol       Date:  2019-12-03       Impact factor: 7.996

4.  Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.

Authors:  Linda Nici; Manoj J Mammen; Edward Charbek; Paul E Alexander; David H Au; Cynthia M Boyd; Gerard J Criner; Gavin C Donaldson; Michael Dreher; Vincent S Fan; Andrea S Gershon; MeiLan K Han; Jerry A Krishnan; Fernando J Martinez; Paula M Meek; Michael Morgan; Michael I Polkey; Milo A Puhan; Mohsen Sadatsafavi; Don D Sin; George R Washko; Jadwiga A Wedzicha; Shawn D Aaron
Journal:  Am J Respir Crit Care Med       Date:  2020-05-01       Impact factor: 21.405

Review 5.  Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis.

Authors:  Victoria S Benson; Sylvia Hartl; Neil Barnes; Nicholas Galwey; Melissa K Van Dyke; Namhee Kwon
Journal:  Eur Respir J       Date:  2022-01-13       Impact factor: 16.671
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.